查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1503265

生育药物和设备市场：2024-2034

Infertility Drugs & Devices Market Report 2024-2034
出版日期: | 出版商: Visiongain | 英文 351 Pages | 商品交期: 最快1-2个工作天内

价格

到2034年，全球生育药物和设备市场规模预计将以 6.2%的年复合成长率成长。

治疗费用高：

在美国，一个週期的体外受精（IVF）费用在 15,000 至 30,000 美元之间，具体取决于设施和患者的需求。药物费用占这些费用的 35%，胚胎基因检测和外科手术等其他额外费用也增加了费用。费用也取决于进行的周期次数，从 1 到 6 个週期不等，给患者带来很大的经济负担。如此高的治疗成本限制了患者的利用和适当的治疗选择，限制了市场的成长。另一方面，保险范围（尤其是在美国）取决于保险计划。在美国，雇主越来越希望承担不孕症治疗费用。

不支持的政府法规：

资金、补助金、政策、补贴和保险等政府法规对 ART 的实施有重大影响。如果没有这样的支持系统，获得治疗服务的机会将受到限制，限制对这些临床服务的使用。在日本，自2022年 4月起，ART 治疗已纳入健康保险范围，作为应对出生率下降的措施。此前，重点是低收入人群，因此只有符合条件的夫妇才能获得部分 ART 治疗补助。韩国和台湾对于资助 ART 治疗有类似的标准。在美国，只有 15 个州制定了允许私人保险公司承担部分或全部不孕不育治疗费用的法律，具体费用因州而异，其中 8 个州仅允许 ART 偿付。大多数欧洲国家允许配子捐赠，包括卵子和精子。精子捐赠在20 个欧盟国家得到认可，卵子捐赠在 27 个欧盟国家中获得 17 个国家的认可。这些法规限制了 ART 的采用，并对市场成长构成了重大障碍。

本报告调查了全球生育药物和设备市场，并提供了市场概况、影响市场成长和市场机会的因素分析、法律和监管环境、市场规模趋势和预测、各个细分市场和地区/编译的详细分析。

目录

第1章 报告概述

第2章 执行摘要

第3章 市场概述

  • 主要发现
  • 市场动态
  • 影响分析
    • 推动市场的因素
    • 市场限制因素
    • 市场机会
  • 供应链分析
  • 监理框架
  • 新兴市场与大趋势
  • 波特五力分析
  • PEST分析

第4章 全球生育药物与设备市场：依产品

  • 主要调查结果
  • 市场吸引力指数
  • 市场规模趋势与预测
  • 药品
  • 设备
  • 培养基和消耗品
  • 配件
    • 市场规模趋势与预测：依地区划分
    • 市占率：依地区划分

第5章 全球生育药物与设备市场：依治疗分类

  • 主要调查结果
  • 市场吸引力指数
  • 市场规模趋势与预测
  • 市占率
  • ART（辅助生殖技术）
  • 人工授精
  • 不孕症治疗手术
  • 其他
    • 市场规模趋势与预测：依地区划分
    • 市占率：依地区划分

第6章 全球生育药物与设备市场：依病患分类

  • 主要调查结果
  • 市场吸引力指数
  • 市场规模趋势与预测
  • 市占率
  • 女性
  • 男性
    • 市场规模趋势与预测：依地区划分
    • 市占率：依地区划分

第7章 全球生育药物和设备市场：依最终用户划分

  • 主要调查结果
  • 市场吸引力指数
  • 市场规模趋势与预测
  • 市占率
  • 生育治疗中心
  • 医院/外科诊所
  • 冷冻银行
  • 研究院
    • 市场规模趋势与预测：依地区划分
    • 市占率：依地区划分

第8章 全球生育药物与设备市场：依地区

  • 主要调查结果
  • 市场规模趋势与预测

第9章 北美生育药物设备市场分析

第10章 欧洲生育药物与设备市场分析

第11章 亚太地区生育药物与设备市场分析

第12章 拉丁美洲生育药物与设备市场分析

第13章 中东与非洲生育药物设备市场分析

第14章 竞争态势

  • 公司排名分析
  • 主要业务策略分析

第15章 公司简介

  • The Cooper Companies, Inc.
  • Vitrolife
  • Thermo Fisher Scientific
  • Hamilton Thorne
  • Esco Micro Pte Ltd
  • FUJIFILM Irvine Scientific
  • The Baker Company
  • Merck KGaA
  • Ferring BV
  • Abbott

第16章 总结/建议

  • Visiongain的总结
  • 对进入市场的公司的建议
Product Code: PHA1346

The global Infertility Drugs & Devices market is projected to grow at a CAGR of 6.2% by 2034

The Infertility Drugs & Devices Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

High cost of treatment

A single IVF cycle ranges from US$15,000 to US$30,000, depending on the centre and the patient needs. Medications constitute 35% of these charges and other additional costs such as genetic testing of the embryos and surgical procedures that increases the cost further. Also, the costs would also depend on number of cycles conducted that range from 1 to 6, which imposes heavy financial burden on the patients. Such high costs limit the use and appropriate treatment option for the patients restricting market growth. Whereas the insurance coverage especially in the U.S. depends on the coverage plans that the employer has offered. Semen analysis is usually covered. However, major parts of the treatment such as embryo transfer, mini-IVF costs, Full IVF cost, using donor egg costs are not completely covered under insurance. There is a growing demand from employers in the U.S. to also provide fertility treatment coverage.

Unsupportive Government Regulations

Government regulations in the form of funding, grants, policies, subsidies, insurance greatly impact the adoption of ART procedures. Lack of these support systems the access to treatment services is restricted and hence leads to limited adoption of these clinical services. For instance, in Japan, ART treatments were initiated to be covered under health insurance since April 2022 as a move to deal with low fertility rates. Prior to this, only eligible couples received partial subsidies for ART treatment due to focus on lower-income citizens in Japan. Similar norms were set up for ART subsidies in Korea and Taiwan. In the U.S. , only 15 states have authorized legislation to private insurers to cover partial or full costs of infertility treatments, however, type of coverage varies by state, with only 8 states authorizing reimbursement for ART. Most European countries allow gametes donation that includes eggs and sperms. Sperm donation is allowed in 20 EU states while Egg donation is permitted in 17 states of the total 27 EU states. These regulations limit the adoption of ART and hence act as a critical barrier in market growth.

What Questions Should You Ask before Buying a Market Research Report?

How is the Infertility Drugs & Devices market evolving?

What is driving and restraining the Infertility Drugs & Devices market?

How will each Infertility Drugs & Devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each Infertility Drugs & Devices submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading Infertility Drugs & Devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the Infertility Drugs & Devices projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of Infertility Drugs & Devices projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the Infertility Drugs & Devices market?

Where is the Infertility Drugs & Devices market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Infertility Drugs & Devices market today, and over the next 10 years:

Our 351-page report provides 156 tables and 245 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Infertility Drugs & Devices prices and recent developments.

Segments Covered in the Report

Product

Drugs

Gonadotropins

Aromatase Inhibitors

Selective Estrogen Receptor Modulators (SERMs)

Dopamine Agonists

Other drug classes

Equipment

Microscopes

Imaging Systems

Sperm Analyzer Systems

Ovum Aspiration Pumps

Micromanipulator Systems

Incubators

Gas Analyzers

Laser Systems

Cryosystems

Sperm Separation Devices

Media & Consumables

Accessories

Procedure

Assisted Reproductive Technology

IVF

Intracytoplasmic Sperm Injection

Surrogacy

Artificial Insemination

Intrauterine

Intracervical

Intratubal

Fertility Surgeries

Laparoscopy

Hysteroscopy

Varicocelectomy

Laparotomy

Tubal Ligation Reversal

Microsurgical Reconstruction

Other Infertility Treatment Procedures

Patient

Female

Male

End-Use

Fertility Centers

Hospitals & Surgical Clinics

Cryobanks

Research Institutes

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Infertility Drugs & Devices Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

Abbott Laboratories

Esco Micro Pte Ltd

Ferring BV

FUJIFILM Irvine Scientific

Hamilton Thorne

Merck KGaA

The Baker Company

The Cooper Companies, Inc.

Thermo Fisher Scientific

Vitrolife

Overall world revenue for Infertility Drugs & Devices Market, 2024 to 2034 in terms of value the market will surpass US$5.9 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Infertility Drugs & Devices Market, 2024 to 2034 report help you?

In summary, our 350+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Infertility Drugs & Devices Market, 2024 to 2034 Market, with forecasts for product, procedure, patient, end-use, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 16 key national markets - See forecasts for the Infertility Drugs & Devices Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Mexico, Brazil, Germany, France, U.K., Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Infertility Drugs & Devices Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Infertility Drugs & Devices Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Infertility Drugs & Devices Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
  • 3.3 Impact Analysis
    • 3.3.1 Market Driving Factors
    • 3.3.2 Market Restraining Factors
    • 3.3.3 Market Opportunities
  • 3.4 Supply Chain Analysis
  • 3.5 Regulatory Framework
  • 3.6 Emerging Markets and Megatrends
  • 3.7 Porter's Five Forces Analysis
    • 3.7.1 Supplier Power
    • 3.7.2 Buyer Power
    • 3.7.3 Competitive Rivalry
    • 3.7.4 Threat of Substitutes
    • 3.7.5 Threat of New Entrants
  • 3.8 PEST Analysis

4 Global Infertility Drugs & Devices Market Analysis by Product

  • 4.1 Key Findings
  • 4.2 Product Segment: Market Attractiveness Index
  • 4.3 Infertility Drugs & Devices Market Size Estimation and Forecast by Product
  • 4.4 Drugs
    • 4.4.1 Drugs Market Forecast by Region, 2024-2034 (US$ Mn)
    • 4.4.2 Drugs Market Share by Region, 2024 and 2034 (%)
    • 4.4.3 Drugs Market Forecast by Type, 2024-2034 (US$ Mn)
    • 4.4.4 Drugs Market Share by Type, 2024 and 2034 (%)
  • 4.5 Equipment
    • 4.5.1 Equipment Market Forecast by Region, 2024-2034 (US$ Mn)
    • 4.5.2 Equipment Market Share by Region, 2024 and 2034 (%)
    • 4.5.3 Equipment Market Forecast by Type, 2024-2034 (US$ Mn)
    • 4.5.4 Equipment Market Share by Type, 2024 and 2034 (%)
  • 4.6 Media & Consumables
    • 4.6.1 Media & Consumables Market Forecast, 2024-2034 (US$ Mn)
    • 4.6.2 Media & Consumables Market Share by Region, 2024 and 2034 (%)
  • 4.7 Accessories
    • 4.7.1 Accessories Market Forecast by Region, 2024-2034 (US$ Mn)
    • 4.7.2 Accessories Market Share by Region, 2024 and 2034 (%)

5 Infertility Drugs & Devices Market Analysis by Procedure

  • 5.1 Key Findings
  • 5.2 Procedure Segment: Market Attractiveness Index
  • 5.3 Infertility Drugs & Devices Market Size Estimation and Forecast by Procedure
  • 5.4 Infertility Drugs & Devices Market Share by Procedure, 2024 & 2034
  • 5.5 Assisted Reproductive Technology
    • 5.5.1 Assisted Reproductive Technology Market Forecast by Region, 2024-2034 (US$ Mn)
    • 5.5.2 Assisted Reproductive Technology Market Share by Region, 2024 and 2034 (%)
    • 5.5.3 Assisted Reproductive Technology Market Forecast by Type, 2024-2034 (US$ Mn)
    • 5.5.4 Assisted Reproductive Technology Market Share by Type, 2024 and 2034 (%)
  • 5.6 Artificial Insemination
    • 5.6.1 Artificial Insemination Market Forecast, 2024-2034 (US$ Mn)
    • 5.6.2 Artificial Insemination Market Share by Region, 2024 and 2034 (%)
    • 5.6.3 Artificial Insemination Market Forecast by Type, 2024-2034 (US$ Mn)
    • 5.6.4 Artificial Insemination Market Share by Type, 2024 and 2034 (%)
  • 5.7 Fertility Surgeries
    • 5.7.1 Fertility Surgeries Market Forecast by Region, 2024-2034 (US$ Mn)
    • 5.7.2 Fertility Surgeries Market Share by Region, 2024 and 2034 (%)
    • 5.7.3 Fertility Surgeries Market Forecast by Type, 2024-2034 (US$ Mn)
    • 5.7.4 Fertility Surgeries Market Share by Type, 2024 and 2034 (%)
  • 5.8 Other Infertility Treatment Procedures
    • 5.8.1 Other Infertility Treatment Procedures Market Forecast by Region, 2024-2034 (US$ Mn)
    • 5.8.2 Other Infertility Treatment Procedures Market Share by Region, 2024 and 2034 (%)

6 Infertility Drugs & Devices Market Analysis by Patient

  • 6.1 Key Findings
  • 6.2 Patient Segment: Market Attractiveness Index
  • 6.3 Infertility Drugs & Devices Market Size Estimation and Forecast by Patient
  • 6.4 Infertility Drugs & Devices Market Share by Patient, 2024, 2029, 2034
  • 6.5 Female
    • 6.5.1 Female Market Forecast by Region, 2024-2034 (US$ Mn)
    • 6.5.2 Female Market Share by Region, 2024 and 2034 (%)
  • 6.6 Male
    • 6.6.1 Male Market Forecast by Region, 2024-2034 (US$ Mn)
    • 6.6.2 Male Market Share by Region, 2024 and 2034 (%)

7 Infertility Drugs & Devices Market Analysis by End-use

  • 7.1 Key Findings
  • 7.2 End-use Segment: Market Attractiveness Index
  • 7.3 Infertility Drugs & Devices Market Size Estimation and Forecast by End-use
  • 7.4 Infertility Drugs & Devices Market Share by End-use, 2024, 2029, 2034
  • 7.5 Fertility Centers
    • 7.5.1 Fertility Centers Market Forecast by Region, 2024-2034 (US$ Mn)
    • 7.5.2 Fertility Centers Market Share by Region, 2024 and 2034 (%)
  • 7.6 Hospitals & Surgical Clinics
    • 7.6.1 Hospitals & Surgical Clinics Market Forecast by Region, 2024-2034 (US$ Mn)
    • 7.6.2 Hospitals & Surgical Clinics Market Share by Region, 2024 and 2034 (%)
  • 7.7 Cryobanks
    • 7.7.1 Cryobanks Market Forecast by Region, 2024-2034 (US$ Mn)
    • 7.7.2 Cryobanks Market Share by Region, 2024 and 2034 (%)
  • 7.8 Research Institutes
    • 7.8.1 Research Institutes Market Forecast by Region, 2024-2034 (US$ Mn)
    • 7.8.2 Research Institutes Market Share by Region, 2024 and 2034 (%)

8 Infertility Drugs & Devices Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America Infertility Drugs & Devices Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Infertility Drugs & Devices Market Attractiveness Index
  • 9.3 North America Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ Mn)
  • 9.4 North America Infertility Drugs & Devices Market Size Estimation and Forecast by Country
  • 9.5 North America Infertility Drugs & Devices Market Size Estimation and Forecast by Product
  • 9.6 North America Infertility Drugs & Devices Market Size Estimation and Forecast by Drugs
  • 9.7 North America Infertility Drugs & Devices Market Size Estimation and Forecast by Equipment
  • 9.8 North America Infertility Drugs & Devices Market Size Estimation and Forecast by Procedure
  • 9.9 North America Infertility Drugs & Devices Market Size Estimation and Forecast by Patient
  • 9.10 North America Infertility Drugs & Devices Market Size Estimation and Forecast by End-users
  • 9.11 U.S.
    • 9.11.1 U.S. Infertility Drugs & Devices Market by Product
  • 9.12 Canada
    • 9.12.1 Canada Infertility Drugs & Devices Market by Product

10 Europe Infertility Drugs & Devices Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe Infertility Drugs & Devices Market Attractiveness Index
  • 10.3 Europe Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ Mn)
  • 10.4 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by Country
  • 10.5 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by Product
  • 10.6 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by Drugs
  • 10.7 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by Equipment
  • 10.8 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by Procedure
  • 10.9 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by Patient
  • 10.10 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by End-use
  • 10.11 Germany
    • 10.11.1 Germany Infertility Drugs & Devices Market by Product
  • 10.12 U.K.
    • 10.12.1 U.K. Infertility Drugs & Devices Market by Product
  • 10.13 France
    • 10.13.1 France Infertility Drugs & Devices Market by Product
  • 10.14 Italy
    • 10.14.1 Italy Infertility Drugs & Devices Market by Product
  • 10.15 Spain
    • 10.15.1 Spain Infertility Drugs & Devices Market by Product
  • 10.16 Rest of Europe
    • 10.16.1 Rest of Europe Infertility Drugs & Devices Market by Product

11 Asia Pacific Infertility Drugs & Devices Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Infertility Drugs & Devices Market Attractiveness Index
  • 11.3 Asia Pacific Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ Mn)
  • 11.4 Asia Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by Product
  • 11.6 Asia Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by Drugs
  • 11.7 Asia Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by Equipment
  • 11.8 Asia-Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by Procedure
  • 11.9 Asia Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by Patient
  • 11.10 Asia Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by End-use
  • 11.11 Japan
    • 11.11.1 Japan Infertility Drugs & Devices Market by Product
  • 11.12 China
    • 11.12.1 China Infertility Drugs & Devices Market by Product
  • 11.13 India
    • 11.13.1 India Infertility Drugs & Devices Market by Product
  • 11.14 South Korea
    • 11.14.1 South Korea Infertility Drugs & Devices Market by Product
  • 11.15 Australia
    • 11.15.1 Australia Infertility Drugs & Devices Market by Product
  • 11.16 Rest of APAC
    • 11.16.1 Rest of APAC Infertility Drugs & Devices Market by Product

12 Latin America Infertility Drugs & Devices Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Infertility Drugs & Devices Market Attractiveness Index
  • 12.3 Latin America Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ Mn)
  • 12.4 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by Country
  • 12.5 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by Product
  • 12.6 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by Drugs
  • 12.7 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by Equipment
  • 12.8 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by Procedure
  • 12.9 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by Patient
  • 12.10 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by End-use

12.11Brazil

    • 12.11.1 Brazil Infertility Drugs & Devices Market by Product
  • 12.12 Mexico
    • 12.12.1 Mexico Infertility Drugs & Devices Market by Product
  • 12.13 Rest of Latin America
    • 12.13.1 Rest of LATAM Infertility Drugs & Devices Market by Product

13 MEA Infertility Drugs & Devices Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA Infertility Drugs & Devices Market Attractiveness Index
  • 13.3 MEA Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ Mn)
  • 13.4 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by Country
  • 13.5 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by Product
  • 13.6 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by Drugs
  • 13.7 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by Equipment
  • 13.8 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by Procedure
  • 13.9 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by Patient
  • 13.10 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by End-use
  • 13.11 South Africa
    • 13.11.1 South Africa Infertility Drugs & Devices Market by Product
  • 13.12 GCC
    • 13.12.1 GCC Infertility Drugs & Devices Market by Product
  • 13.13 Rest of MEA
    • 13.13.1 Rest of MEA Infertility Drugs & Devices Market by Product

14 Competitive Landscape

  • 14.1 Company Ranking Analysis
  • 14.2 Key Business Strategy Analysis

15 Company Profiles

  • 15.1 The Cooper Companies, Inc.
    • 15.1.1 Company Snapshot
    • 15.1.2 Company Overview
    • 15.1.3 Financial Analysis
    • 15.1.4 Product Benchmarking
    • 15.1.5 Strategic Outlook
    • 15.1.6 SWOT Analysis
  • 15.2 Vitrolife
    • 15.2.1 Company Snapshot
    • 15.2.2 Company Overview
    • 15.2.3 Financial Analysis
    • 15.2.4 Product Benchmarking
    • 15.2.5 Strategic Outlook
  • 15.3 Thermo Fisher Scientific
    • 15.3.1 Company Snapshot
    • 15.3.2 Company Overview
    • 15.3.3 Financial Analysis
    • 15.3.4 Product Benchmarking
    • 15.3.5 Strategic Outlook
  • 15.4 Hamilton Thorne
    • 15.4.1 Company Snapshot
    • 15.4.2 Company Overview
    • 15.4.3 Financial Analysis
    • 15.4.4 Product Benchmarking
    • 15.4.5 Strategic Outlook
  • 15.5 Esco Micro Pte Ltd
    • 15.5.1 Company Snapshot
    • 15.5.2 Company Overview
    • 15.5.3 Product Benchmarking
    • 15.5.4 Strategic Outlook
  • 15.6 FUJIFILM Irvine Scientific
    • 15.6.1 Company Snapshot
    • 15.6.2 Company Overview
    • 15.6.3 Financial Analysis
    • 15.6.4 Product Benchmarking
    • 15.6.5 Strategic Outlook
    • 15.6.6 SWOT Analysis
  • 15.7 The Baker Company
    • 15.7.1 Company Snapshot
    • 15.7.2 Company Overview
    • 15.7.3 Product Benchmarking
    • 15.7.4 Strategic Outlook
  • 15.8 Merck KGaA
    • 15.8.1 Company Snapshot
    • 15.8.2 Company Overview
    • 15.8.3 Financial Analysis
    • 15.8.4 Product Benchmarking
    • 15.8.5 Strategic Outlook
  • 15.9 Ferring BV
    • 15.9.1 Company Snapshot
    • 15.9.2 Company Overview
    • 15.9.3 Product Benchmarking
    • 15.9.4 Strategic Outlook
    • 15.9.5 SWOT Analysis
  • 15.10 Abbott
    • 15.10.1 Company Snapshot
    • 15.10.2 Company Overview
    • 15.10.3 Financial Analysis
    • 15.10.4 Product Benchmarking

16 Conclusion and Recommendations

  • 16.1 Concluding Remarks from Visiongain
  • 16.2 Recommendations for Market Players

List of Tables

  • Table 1 Infertility Drugs & Devices Market Snapshot, 2024 & 2034 (US$ million, CAGR %)
  • Table 2 Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 3 Drugs Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 4 Drugs Market, by Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 5 Gonadotropin Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 6 Aromatase Inhibitors Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 7 Selective Estrogen Receptor Modulators Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 8 Dopamine Agonists Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 9 Other Drug Classes Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 10 Equipment Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 11 Equipment Market, By Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 12 Microscopes Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 13 Imaging Systems Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 14 Sperm Analyzer Systems Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 15 Ovum Aspiration Pumps Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 16 Micromanipulator Systems Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 17 Incubators Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 18 Gas Analyzers Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 19 Laser Systems Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 20 Cryosystems Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 21 Sperm Separation Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 22 Media & Consumables Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 23 Accessories Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 24 Infertility Drugs & Devices Procedure Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 25 Assisted Reproductive Technology Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 26 Assisted Reproductive Technology Market, By Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 27 IVF Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 28 Intracytoplasmic Sperm Injection Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 29 Surrogacy Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 30 Artificial Insemination Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 31 Artificial Insemination Market, By Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 32 Intrauterine Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 33 Intracervical Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 34 Intratubal Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 35 Fertility Surgeries Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 36 Fertility Surgeries Market, By Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 37 Laparoscopy Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 38 Hysteroscopy Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 39 Varicocelectomy Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 40 Laparotomy Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 41 Tubal Ligation Reversal Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 42 Microsurgical Reconstruction Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 43 Other Infertility Treatment Procedures Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 44 Infertility Drugs & Devices Patient Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 45 Female Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 46 Male Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 47 Infertility Drugs & Devices End Use Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 48 Fertility Centers Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 49 Hospitals & Surgical Clinics Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 50 Cryobanks Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 51 Research Institutes Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 52 Infertility Drugs & Devices Market, By Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 53 North America Infertility Drugs & Devices Market, By Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 54 North America Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 55 North America Infertility Drugs Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 56 North America Infertility Equipment Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 57 North America Infertility Drugs & Devices Procedure Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 58 North America Patient Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 59 North America Infertility Drugs & Devices End Users Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 60 U.S. Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 61 U.S. Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 62 Canada Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 63 Canada Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 64 Europe Infertility Drugs & Devices Market, By Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 65 Europe Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 66 Europe Infertility Drugs Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 67 Europe Infertility Equipment Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 68 Europe Infertility Drugs & Devices Procedure Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 69 Europe Patient Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 70 Europe Infertility Drugs & Devices End-use Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 71 Germany Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 72 Germany Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 73 UK Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 74 UK Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 75 France Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 76 France Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 77 Italy Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 78 Italy Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 79 Spain Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 80 Spain Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 81 Rest of Europe Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 82 Rest of Europe Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 83 Asia Pacific Infertility Drugs & Devices Market, By Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 84 Asia Pacific Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 85 Asia-Pacific Infertility Drugs Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 86 Asia-Pacific Infertility Equipment Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 87 Asia-Pacific Infertility Drugs & Devices Procedure Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 88 Asia-Pacific Patient Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 89 Asia-Pacific Infertility Drugs & Devices End-use Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 90 Japan Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 91 Japan Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 92 China Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 93 China Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 94 India Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 95 India Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 96 South Korea Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 97 South Korea Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 98 Australia Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 99 Australia Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 100 Rest of Asia Pacific Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 101 Rest of Asia Pacific Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 102 Latin America Infertility Drugs & Devices Market, By Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 103 Latin America Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 104 Latin America Infertility Drugs Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 105 Latin America Infertility Equipment Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 106 Latin America Infertility Drugs & Devices Procedure Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 107 Latin America Patient Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 108 Latin America Infertility Drugs & Devices End-use Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 109 Brazil Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 110 Brazil Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 111 Mexico Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 112 Mexico Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 113 Rest of Latin America Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 114 Rest of LATAM Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 115 MEA Infertility Drugs & Devices Market, By Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 116 MEA Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 117 MEA Infertility Drugs Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 118 MEA Infertility Equipment Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 119 MEA Infertility Drugs & Devices Procedure Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 120 MEA Patient Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 121 MEA Infertility Drugs & Devices End-use Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 122 South Africa Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 123 South Africa Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 124 GCC Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 125 GCC Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 126 Rest of MEA Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 127 Rest of MEA Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
  • Table 128 Key Business Strategies Adopted by Key Players in Infertility Drugs & Devices Market Details
  • Table 129 The Cooper Companies, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 130 The Cooper Companies, Inc. : Product Benchmarking
  • Table 131 The Cooper Companies, Inc. : Company Recent Developments
  • Table 132 Vitrolife: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 133 Vitrolife: Product Benchmarking
  • Table 134 Vitrolife : Company Recent Developments
  • Table 135 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 136 Thermo Fisher Scientific: Product Benchmarking
  • Table 137 Thermo Fisher Scientific : Company Recent Developments
  • Table 138 Hamilton Thorne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 139 Hamilton Thorne: Product Benchmarking
  • Table 140 Hamilton Thorne: Company Recent Developments
  • Table 141 Esco Micro Pte Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 142 Esco Micro Pte Ltd: Product Benchmarking
  • Table 143 Esco Micro Pte Ltd: Company Recent Developments
  • Table 144 FUJIFILM Irvine Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 145 FUJIFILM Irvine Scientific: Product Benchmarking
  • Table 146 FUJIFILM Irvine Scientific: Company Recent Developments
  • Table 147 The Baker Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 148 The Baker Company: Product Benchmarking
  • Table 149 The Baker Company: Company Recent Developments
  • Table 150 Merck KGaA : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 151 Merck KGaA : Product Benchmarking
  • Table 152 Merck KGaA : Company Recent Developments
  • Table 153 Ferring BV: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 154 Ferring BV: Product Benchmarking
  • Table 155 Ferring BV: Company Recent Developments
  • Table 156 Abbott : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 157 Abbott : Product Benchmarking

List of Figures

  • Figure 1 Infertility Drugs & Devices Market Segmentation
  • Figure 2 Infertility Drugs & Devices Market Forecast by Region: Market Attractiveness Index
  • Figure 3 Infertility Drugs & Devices Market by Product: Market Attractiveness Index
  • Figure 4 Infertility Drugs & Devices Market by Procedure: Market Attractiveness Index
  • Figure 5 Infertility Drugs & Devices Market by Patient: Market Attractiveness Index
  • Figure 6 Infertility Drugs & Devices Market by End-use: Market Attractiveness Index
  • Figure 1 Infertility Drugs & Devices Market: Market Dynamics
  • Figure 7 Infertility Drugs & Devices Market: Impact Analysis
  • Figure 8 Infertility Drugs & Devices Market: Supply Chain Analysis
  • Figure 2 Infertility Drugs & Devices Market: Porter's Five Forces Analysis
  • Figure 3 Infertility Drugs & Devices Market: PEST Analysis
  • Figure 4 Infertility Drugs & Devices Market Forecast by Product 2024 (Revenue, CAGR%)
  • Figure 5 Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 6 Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 7 Drugs Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 8 Drugs Market Share Forecast by Region, 2024 and 2034 (%)
  • Figure 9 Drugs Market Forecast by Type, 2024-2034 (US$ million)
  • Figure 10 Drugs Market Share Forecast by Type, 2024 and 2034 (%)
  • Figure 11 Gonadotropins Market Forecast, 2024-2034 (US$ million)
  • Figure 12 Aromatase Inhibitors Market Forecast, 2024-2034 (US$ million)
  • Figure 13 Selective Estrogen Receptor Modulators (SERMs) Market Forecast, 2024-2034 (US$ million)
  • Figure 14 Dopamine Agonists Market Forecast, 2024-2034 (US$ million)
  • Figure 15 Other Drug Classes Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 16 Equipment Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 17 Equipment Market Share Forecast by Region, 2024 and 2034 (%)
  • Figure 18 Equipment Market Forecast by Type, 2024-2034 (US$ million)
  • Figure 19 Equipment Market Share Forecast by Type, 2024 and 2034 (%)
  • Figure 20 Microscopes Market Forecast, 2024-2034 (US$ million)
  • Figure 21 Imaging Systems Market Forecast, 2024-2034 (US$ million)
  • Figure 22 Sperm Analyzer Systems Market Forecast, 2024-2034 (US$ million)
  • Figure 23 Ovum Aspiration Pumps Market Forecast, 2024-2034 (US$ million)
  • Figure 24 Micromanipulator Systems Market Forecast, 2024-2034 (US$ million)
  • Figure 25 Incubators Market Forecast, 2024-2034 (US$ million)
  • Figure 26 Gas Analyzers Market Forecast, 2024-2034 (US$ million)
  • Figure 27 Laser Systems Market Forecast, 2024-2034 (US$ million)
  • Figure 28 Cryosystems Market Forecast, 2024-2034 (US$ million)
  • Figure 29 Sperm Separation Devices Market Forecast, 2024-2034 (US$ million)
  • Figure 30 Media & Consumables Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 31 Media & Consumables Market Share Forecast by Region, 2024 and 2034 (%)
  • Figure 32 Accessories Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 33 Accessories Market Share Forecast by Region, 2024-2034 (%)
  • Figure 34 Infertility Drugs & Devices Market Forecast by Procedure 2024 (Revenue, CAGR%)
  • Figure 35 Infertility Drugs & Devices Market Forecast by Procedure, 2024-2034 (US$ Million, AGR %)
  • Figure 36 Infertility Drugs & Devices Market Share Forecast by Procedure, 2024 and 2034 (%)
  • Figure 37 Assisted Reproductive Technology Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 38 Assisted Reproductive Technology Market Share Forecast by Region, 2024 and 2034 (%)
  • Figure 39 Assisted Reproductive Technology Market Forecast by Type, 2024-2034 (US$ million)
  • Figure 40 Assisted Reproductive Technology Market Share Forecast by Type, 2024 and 2034 (%)
  • Figure 41 IVF Market Forecast, 2024-2034 (US$ million)
  • Figure 42 Intracytoplasmic Sperm Injection Market Forecast, 2024-2034 (US$ million)
  • Figure 43 Surrogacy Market Forecast, 2024-2034 (US$ million)
  • Figure 44 Artificial Insemination Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 45 Artificial Insemination Market Share Forecast by Region, 2024 and 2034 (%)
  • Figure 46 Artificial Insemination Market Forecast by Type, 2024-2034 (US$ million)
  • Figure 47 Artificial Insemination Market Share Forecast by Type, 2024 and 2034 (%)
  • Figure 48 Intrauterine Market Forecast, 2024-2034 (US$ million)
  • Figure 49 Intracervical Market Forecast, 2024-2034 (US$ million)
  • Figure 50 Intratubal Market Forecast, 2024-2034 (US$ million)
  • Figure 51 Fertility Surgeries Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 52 Fertility Surgeries Market Share Forecast by Region, 2024 and 2034 (%)
  • Figure 53 Fertility Surgeries Market Forecast by Type, 2024-2034 (US$ million)
  • Figure 54 Fertility Surgeries Market Share Forecast by Type, 2024 and 2034 (%)
  • Figure 55 Laparoscopy Market Forecast, 2024-2034 (US$ million)
  • Figure 56 Hysteroscopy Market Forecast, 2024-2034 (US$ million)
  • Figure 57 Varicocelectomy Market Forecast, 2024-2034 (US$ million)
  • Figure 58 Laparotomy Market Forecast, 2024-2034 (US$ million)
  • Figure 59 Tubal Ligation Reversal Market Forecast, 2024-2034 (US$ million)
  • Figure 60 Microsurgical Reconstruction Market Forecast, 2024-2034 (US$ million)
  • Figure 61 Other Infertility Treatment Procedures Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 62 Other Infertility Treatment Procedures Market Share Forecast by Region, 2024 and 2034 (%)
  • Figure 63 Infertility Drugs & Devices Market Forecast by Patient 2024 (Revenue, CAGR%)
  • Figure 64 Infertility Drugs & Devices Market Forecast by Patient, 2024-2034 (US$ Million, AGR %)
  • Figure 65 Infertility Drugs & Devices Market Share Forecast by Patient, 2024, 2029, 2034 (%)
  • Figure 66 Female Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 67 Female Market Share Forecast by Region, 2024 and 2034 (%)
  • Figure 68 Male Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 69 Male Market Share Forecast by Region, 2024 and 2034 (%)
  • Figure 70 Infertility Drugs & Devices Market Forecast by End-use 2024 (Revenue, CAGR%)
  • Figure 71 Infertility Drugs & Devices Market Forecast by End-use, 2024-2034 (US$ Million, AGR %)
  • Figure 72 Infertility Drugs & Devices Market Share Forecast by End-use, 2024, 2029, 2034 (%)
  • Figure 73 Fertility Centers Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 74 Fertility Centers Market Share Forecast by Region, 2024 and 2034 (%)
  • Figure 75 Hospitals & Surgical Clinics Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 76 Hospitals & Surgical Clinics Market Share Forecast by Region, 2024 and 2034 (%)
  • Figure 77 Cryobanks Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 78 Cryobanks Market Share Forecast by Region, 2024 and 2034 (%)
  • Figure 79 Research Institutes Market Forecast by Region, 2024-2034 (US$ million)
  • Figure 80 Research Institutes Market Share Forecast by Region, 2024 and 2034 (%)
  • Figure 81 Infertility Drugs & Devices Market Forecast by Region 2024, 2034 (Revenue)
  • Figure 82 Infertility Drugs & Devices Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 83 Infertility Drugs & Devices Market by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
  • Figure 84 North America Infertility Drugs & Devices Market Attractiveness Index, 2024
  • Figure 85 North America Infertility Drugs & Devices Market by Region, 2024, 2029 & 2034 (US$ million)
  • Figure 86 North America Infertility Drugs & Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 87 North America Infertility Drugs & Devices Market Share Forecast by Country, 2024, 2029, 2034(%)
  • Figure 88 North America Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 89 North America Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 90 North America Infertility Drugs & Devices Market Forecast by Drugs, 2024-2034 (US$ Million, AGR %)
  • Figure 91 North America Infertility Drugs & Devices Market Share Forecast by Drugs, 2024, 2029, 2034 (%)
  • Figure 92 North America Infertility Drugs & Devices Market Forecast by Equipment, 2024-2034 (US$ Million, AGR %)
  • Figure 93 North America Infertility Drugs & Devices Market Share Forecast by Equipment, 2024, 2029, 2034 (%)
  • Figure 94 North America Infertility Drugs & Devices Market Forecast by Procedure, 2024-2034 (US$ Million, AGR %)
  • Figure 95 North America Infertility Drugs & Devices Market Share Forecast by Procedure, 2024, 2029, 2034 (%)
  • Figure 96 North America Infertility Drugs & Devices Market Forecast by Patient, 2024-2034 (US$ Million, AGR %)
  • Figure 97 North America Infertility Drugs & Devices Market Share Forecast by Patient, 2024, 2029, 2034 (%)
  • Figure 98 North America Infertility Drugs & Devices Market Forecast by End-use, 2024-2034 (US$ Million, AGR %)
  • Figure 99 North America Infertility Drugs & Devices Market Share Forecast by End-use, 2024, 2029, 2034 (%)
  • Figure 100 U.S. Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 101 U.S. Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 102 U.S. Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 103 Canada Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 104 Canada Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 105 Canada Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 106 Europe Infertility Drugs & Devices Market Attractiveness Index, 2024
  • Figure 107 Europe Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ million)
  • Figure 108 Europe Infertility Drugs & Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 109 Europe Infertility Drugs & Devices Market Share Forecast by Country, 2024, 2029, 2034 (%)
  • Figure 110 Europe Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 111 Europe Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 112 Europe Infertility Drugs & Devices Market Forecast by Drugs, 2024-2034 (US$ Million, AGR %)
  • Figure 113 Europe Infertility Drugs & Devices Market Share Forecast by Drugs, 2024, 2029, 2034 (%)
  • Figure 114 Europe Infertility Drugs & Devices Market Forecast by Equipment, 2024-2034 (US$ Million, AGR %)
  • Figure 115 Europe Infertility Drugs & Devices Market Share Forecast by Equipment, 2024, 2029, 2034 (%)
  • Figure 116 Europe Infertility Drugs & Devices Market Forecast by Procedure, 2024-2034 (US$ Million, AGR %)
  • Figure 117 Europe Infertility Drugs & Devices Market Share Forecast by Procedure, 2024, 2029, 2034 (%)
  • Figure 118 Europe Infertility Drugs & Devices Market Forecast by Patient, 2024-2034 (US$ Million, AGR %)
  • Figure 119 Europe Infertility Drugs & Devices Market Share Forecast by Patient, 2024, 2029, 2034 (%)
  • Figure 120 Europe Infertility Drugs & Devices Market Forecast by End-use, 2024-2034 (US$ Million, AGR %)
  • Figure 121 Europe Infertility Drugs & Devices Market Share Forecast by End-use, 2024, 2029, 2034 (%)
  • Figure 122 Germany Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 123 Germany Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 124 Germany Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 125 U.K. Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 126 U.K. Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 127 U.K. Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 128 France Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 129 France Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 130 France Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 131 Italy Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 132 Italy Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 133 Italy Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 134 Spain Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 135 Spain Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 136 Spain Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 137 Rest of Europe Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 138 Rest of Europe Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 139 Rest of Europe Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 140 Asia Pacific Infertility Drugs & Devices Market Attractiveness Index, 2024
  • Figure 141 Asia Pacific Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ million)
  • Figure 142 Asia Pacific Infertility Drugs & Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 143 Asia Pacific Infertility Drugs & Devices Market Share Forecast by Country, 2024, 2029, 2034 (%)
  • Figure 144 Asia Pacific Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 145 Asia Pacific Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 146 Asia Pacific Infertility Drugs & Devices Market Forecast by Drugs, 2024-2034 (US$ Million, AGR %)
  • Figure 147 Asia Pacific Infertility Drugs & Devices Market Share Forecast by Drugs, 2024, 2029, 2034 (%)
  • Figure 148 Asia Pacific Infertility Drugs & Devices Market Forecast by Equipment, 2024-2034 (US$ Million, AGR %)
  • Figure 149 Asia Pacific Infertility Drugs & Devices Market Share Forecast by Equipment, 2024, 2029, 2034 (%)
  • Figure 150 Asia-Pacific Infertility Drugs & Devices Market Forecast by Procedure, 2024-2034 (US$ Million, AGR %)
  • Figure 151 Asia-Pacific Infertility Drugs & Devices Market Share Forecast by Procedure, 2024, 2029, 2034 (%)
  • Figure 152 Asia Pacific Infertility Drugs & Devices Market Forecast by Patient, 2024-2034 (US$ Million, AGR %)
  • Figure 153 Asia Pacific Infertility Drugs & Devices Market Share Forecast by Patient, 2024, 2029, 2034 (%)
  • Figure 154 Asia Pacific Infertility Drugs & Devices Market Forecast by End-use, 2024-2034 (US$ Million, AGR %)
  • Figure 155 Asia Pacific Infertility Drugs & Devices Market Share Forecast by End-use, 2024, 2029, 2034 (%)
  • Figure 156 Japan Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 157 Japan Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 158 Japan Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 159 China Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 160 China Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 161 China Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 162 India Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 163 India Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 164 India Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 165 South Korea Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 166 South Korea Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 167 South Korea Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 168 Australia Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 169 Australia Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 170 Australia Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 171 Rest of Asia Pacific Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 172 Rest of APAC Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 173 Rest of APAC Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 174 Latin America Infertility Drugs & Devices Market Attractiveness Index, 2024
  • Figure 175 Latin America Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ million)
  • Figure 176 Latin America Infertility Drugs & Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 177 Latin America Infertility Drugs & Devices Market Share Forecast by Country, 2024, 2029, 2034 (%)
  • Figure 178 Latin America Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 179 Latin America Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 180 Latin America Infertility Drugs & Devices Market Forecast by Drugs, 2024-2034 (US$ Million, AGR %)
  • Figure 181 Latin America Infertility Drugs & Devices Market Share Forecast by Drugs, 2024, 2029, 2034 (%)
  • Figure 182 Latin America Infertility Drugs & Devices Market Forecast by Equipment, 2024-2034 (US$ Million, AGR %)
  • Figure 183 Latin America Infertility Drugs & Devices Market Share Forecast by Equipment, 2024, 2029, 2034 (%)
  • Figure 184 Latin America Infertility Drugs & Devices Market Forecast by Procedure, 2024-2034 (US$ Million, AGR %)
  • Figure 185 Latin America Infertility Drugs & Devices Market Share Forecast by Procedure, 2024, 2029, 2034 (%)
  • Figure 186 Latin America Infertility Drugs & Devices Market Forecast by Patient, 2024-2034 (US$ Million, AGR %)
  • Figure 187 Latin America Infertility Drugs & Devices Market Share Forecast by Patient, 2024, 2029, 2034 (%)
  • Figure 188 Latin America Infertility Drugs & Devices Market Forecast by End-use, 2024-2034 (US$ Million, AGR %)
  • Figure 189 Latin America Infertility Drugs & Devices Market Share Forecast by End-use, 2024, 2029, 2034 (%)
  • Figure 190 Brazil Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 191 Brazil Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 192 Brazil Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 193 Mexico Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 194 Mexico Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 195 Mexico Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 196 Rest of LATAM Infertility Drugs & Devices Mar